AU2003225866A1 - Peptide epitopes recognized by antigen specific cd8+ t lymphocytes - Google Patents

Peptide epitopes recognized by antigen specific cd8+ t lymphocytes

Info

Publication number
AU2003225866A1
AU2003225866A1 AU2003225866A AU2003225866A AU2003225866A1 AU 2003225866 A1 AU2003225866 A1 AU 2003225866A1 AU 2003225866 A AU2003225866 A AU 2003225866A AU 2003225866 A AU2003225866 A AU 2003225866A AU 2003225866 A1 AU2003225866 A1 AU 2003225866A1
Authority
AU
Australia
Prior art keywords
lymphocytes
antigen specific
peptide epitopes
epitopes recognized
recognized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003225866A
Inventor
Roman M. Chicz
Andrew J. Tomlinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
MGI Pharma Biologics Inc
Original Assignee
Zycos Inc
Aventis Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zycos Inc, Aventis Pasteur Inc filed Critical Zycos Inc
Publication of AU2003225866A1 publication Critical patent/AU2003225866A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003225866A 2002-03-22 2003-03-20 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes Abandoned AU2003225866A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36682202P 2002-03-22 2002-03-22
US60/366,822 2002-03-22
PCT/US2003/008427 WO2003082317A1 (en) 2002-03-22 2003-03-20 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes

Publications (1)

Publication Number Publication Date
AU2003225866A1 true AU2003225866A1 (en) 2003-10-13

Family

ID=28675284

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003225866A Abandoned AU2003225866A1 (en) 2002-03-22 2003-03-20 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes

Country Status (2)

Country Link
AU (1) AU2003225866A1 (en)
WO (1) WO2003082317A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10313819A1 (en) * 2003-03-24 2004-10-07 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to MHC molecules
CN102719400B (en) * 2012-07-05 2014-04-09 时宏珍 Preparation method of HLA-A0201 restrictive anti-carcinoembryonic antigen (CEA) antigenic specificity cytotoxic T lymphocyte (CTL)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

Also Published As

Publication number Publication date
WO2003082317A9 (en) 2004-10-28
WO2003082317A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AU2003219277A1 (en) Intracellular antibodies
AU2003264009A1 (en) Humanized rabbit antibodies
AU2003217912A1 (en) Antibody optimization
AU2003262094A1 (en) Cancer antigen peptide preparation
AU2003209059A1 (en) Human monoclonal antibodies against membrane proteins
AU2003239197A1 (en) Novel stable anti-cd22 antibodies
AU2003285540A1 (en) Antibody for the thyrotropin receptor and uses thereof
AU2002254511A1 (en) Multiple simultaneous antigen detection by immunohistochemistry
AU2003257032A1 (en) Antibodies against c3a receptor
AU2003294120A1 (en) Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
AU2003290563A1 (en) Leptin-related peptides
AU2003294220A1 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
EP1558628A4 (en) Antigenic peptides
AU2003283963A1 (en) Mage-c2 antigenic peptides and uses thereof
AU2003301316A1 (en) Improved immunotherapy
AU2001290801A1 (en) Peptide epitopes recognized by antigen specific cd4+ t lymphocytes
AU2003225866A1 (en) Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
AU2003302234A1 (en) Immune response associated proteins
AUPS148202A0 (en) Immunotherapeutic and immunoprophylactic reagents
AU2003261254A1 (en) Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof
AU2003229799A1 (en) Novel humanized anti-vap-1 monoclonal antibody
AU2003271093A1 (en) Antigen recognizing antibody
AU2003221569A1 (en) Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
AU2003236346A1 (en) Monoclonal antibody neutralizing megsin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase